Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ConvaTec ( (GB:CTEC) ) just unveiled an announcement.
ConvaTec Group PLC has announced the purchase of 1,439,340 ordinary shares as part of its $300 million share buyback program, initially announced in August 2025. The shares were acquired at prices ranging from 223.00 to 227.20 pence, with an average price of 225.69 pence per share, and will be held in treasury. This move is part of ConvaTec’s strategy to optimize its capital structure and enhance shareholder value, reflecting confidence in its financial health and future prospects.
The most recent analyst rating on (GB:CTEC) stock is a Hold with a £253.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.
ConvaTec’s strong financial performance is the primary driver of its stock score, supported by consistent revenue growth and solid profitability. However, technical analysis indicates potential bearish trends, and the valuation appears stretched, limiting upside potential. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC is a global medical products and technologies company, primarily focusing on providing advanced wound care, ostomy care, continence and critical care, and infusion care products. The company aims to improve the lives of people with chronic conditions and is positioned in the healthcare sector.
Average Trading Volume: 8,171,315
Technical Sentiment Signal: Hold
Current Market Cap: £4.53B
Learn more about CTEC stock on TipRanks’ Stock Analysis page.